📣 VC round data is live. Check it out!

B-Act Valuation Multiples

Discover revenue and EBITDA valuation multiples for B-Act and similar public comparables like Hexicon, Proodeftiki Technical, GCDI, FBS Global Limited and more.

B-Act Overview

About B-Act

B-Act SA is an engineering consulting company. The company is engaged in management, consulting, and supervision in the implementation of construction projects in Poland, Romania, Ukraine and the Baltic States. The company provide comprehensive services including representing the investor, technical, economic, financial and legal advice, as well as controlling the course of the investment process with the use of modern IT tools.


Founded

1994

HQ

Poland

Employees

N/A

Website

b-act.com.

Financials (FY)

Revenue: $9M
EBITDA: $856K

EV

$8M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

B-Act Financials

B-Act reported last fiscal year revenue of $9M and EBITDA of $856K.

In the same fiscal year, B-Act generated $9M in gross profit, $856K in EBITDA, and $502K in net income.


B-Act P&L

In the most recent fiscal year, B-Act reported revenue of $9M and EBITDA of $856K.

B-Act is profitable as of last fiscal year, with gross margin of 99%, EBITDA margin of 9%, and net margin of 5%.

See analyst estimates for B-Act
Last FY202320242025202620272028
Revenue$9M$4M$8M$9M
Gross Profit$9M$4M$8M$9M
Gross Margin99%101%98%99%
EBITDA$856K$620K$746K$856K
EBITDA Margin9%16%10%9%
EBIT Margin7%16%8%7%
Net Profit$502K$445K$471K$502K
Net Margin5%11%6%5%

Financial data powered by Morningstar, Inc.

B-Act Stock Performance

B-Act has current market cap of $9M, and enterprise value of $8M.

Market Cap Evolution


B-Act's stock price is $0.93.

B-Act share price increased by 13.1% in the last 30 days, and by 56.7% in the last year.

B-Act has an EPS (earnings per share) of $0.05.

See more trading valuation data for B-Act
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$8M$9M-1.6%13.1%-15.8%56.7%$0.05

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

B-Act Valuation Multiples

B-Act trades at 0.8x EV/Revenue multiple, and 9.0x EV/EBITDA.

See NTM and 2027E valuation multiples for B-Act

B-Act Financial Valuation Multiples

As of May 13, 2026, B-Act has market cap of $9M and EV of $8M.

B-Act has a P/E ratio of 18.2x.

Last FY202320242025202620272028
EV/Revenue0.8x1.9x1.0x0.8x
EV/EBITDA9.0x12.4x10.3x9.0x
EV/EBIT11.4x12.0x12.2x11.4x
EV/Gross Profit0.8x1.9x1.0x0.8x
P/E18.2x20.6x19.4x18.2x
EV/FCF13.7x11.0x(11.3x)13.7x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified B-Act Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

B-Act Margins & Growth Rates

In the most recent fiscal year, B-Act reported gross margin of 99%, EBITDA margin of 9%, and net margin of 5%.

See estimated margins and future growth rates for B-Act

B-Act Margins

Last FY20242025202720282029
Gross Margin99%98%99%
EBITDA Margin9%10%9%
EBIT Margin7%8%7%
Net Margin5%6%5%
FCF Margin6%(9%)6%

B-Act Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth97%17%
Gross Profit Growth91%18%
EBITDA Growth20%15%
EBIT Growth(1%)6%
Net Profit Growth6%6%
FCF Growth(197%)(183%)

Data powered by FactSet, Inc. and Morningstar, Inc.

B-Act Operational KPIs

Access forward-looking KPIs for B-Act
Last FY202320242025202620272028
Opex to Revenue92%85%90%92%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

B-Act Competitors

B-Act competitors include Hexicon, Proodeftiki Technical, GCDI, FBS Global Limited, Esi, Delattre Levivier Maroc, Ten-League International, Renovalo, Mostostal Plock and Navstone.

Most B-Act public comparables operate across Construction & Engineering.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Hexicon47.4x21.6x
Proodeftiki Technical
GCDI0.5x(5.7x)
FBS Global Limited0.2x(5.2x)
Esi0.5x0.5x10.5x7.4x
Delattre Levivier Maroc
Ten-League International0.4x2.4x
Renovalo(0.1x)(1.0x)

This data is available for Pro users. Sign up to see all B-Act competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About B-Act

When was B-Act founded?B-Act was founded in 1994.
Where is B-Act headquartered?B-Act is headquartered in Poland.
Is B-Act publicly listed?Yes, B-Act is a public company listed on Warsaw Stock Exchange.
What is the stock symbol of B-Act?B-Act trades under BAC ticker.
When did B-Act go public?B-Act went public in 2024.
Who are competitors of B-Act?B-Act main competitors include Hexicon, Proodeftiki Technical, GCDI, FBS Global Limited, Esi, Delattre Levivier Maroc, Ten-League International, Renovalo, Mostostal Plock, Navstone.
What is the current market cap of B-Act?B-Act's current market cap is $9M.
What is the current revenue of B-Act?B-Act's last fiscal year revenue is $9M.
What is the current EV/Revenue multiple of B-Act?Current revenue multiple of B-Act is 0.8x.
Is B-Act profitable?No, B-Act is not profitable.
How many companies B-Act has acquired to date?B-Act hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies B-Act has invested to date?B-Act hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to B-Act

Lists including B-Act

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial